Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

Vergès, Bruno; Avignon, A.; Bonnet, Fabrice; Catargi, Bogdan; Cattan, Simon; Cosson, E.; Ducrocq, Grégory; Elbaz, Meyer; Fredenrich, A.; Gourdy, Pierre; Henry, Patrick; Lairez, O.; Leguerrier, Anne-Marie; C, Monpère; Moulin, Philippe; Vergès-Patois, Bénédicte; Roussel, Ronan; Steg, Philippe Gabriel; Valensi, P.

doi:10.1016/j.diabet.2011.11.003

Cited by 46 publications

(33 citation statements)

References 108 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Zakres kontroli glikemii u pacjentów z cukrzycą i NSTE-ACS budzi kontrowersje, gdyż coraz częściej zauważa się szkodliwy wpływ hipoglikemii na wyniki CV [431]. Zgodnie z wytycznymi ESC/European Association for the Study of Diabetes należy rozważyć leczenie obniżające glikemię u pacjentów z NSTE--ACS z istotną hiperglikemią [stężenie glukozy > 10 mmol/l (> 180-200 mg/dl)], a docelowe wartości glikemii należy dostosować do chorób współistniejących w celu uniknięcia ciężkiej hipoglikemii [< 5 mmol/l (< 90 mg/dl)] [432][433][434]. Ogólnie należy przyjąć, że im bardziej zaawansowana choroba CV, starszy wiek, dłuższy czas trwania cukrzycy i im więcej chorób współistniejących, tym mniej rygorystyczna kontrola stężenia glukozy powinna być zastosowana w ostrej fazie choroby i w okresie dalszej obserwacji.…”

Section: Cukrzycaunclassified

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Roffi¹,

Patrono²,

Collet³

et al. 2015

Kardiol Pol

207

165

View full text Add to dashboard Cite

Section: Cukrzycaunclassified

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Roffi¹,

Patrono²,

Collet³

et al. 2015

Kardiol Pol

207

165

View full text Add to dashboard Cite

“…Surprisingly, after 3 months, all of the undiagnosed preexisting diabetes patients remained diabetic, while only 16.7% of the stress hyperglycemia patients remained diabetic [45]. Thus, new consensus statements on the care of the hyperglycemia in ACS patients have recommended its use during hospitalization with an OGTT [46]. …”

Section: Discussionmentioning

confidence: 99%

The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy

Xie

Zhao

et al. 2012

Cardiovasc Diabetol

View full text Add to dashboard Cite

BackgroundThe appropriateness of the routine performance of an oral glucose tolerance test (OGTT) to screen for diabetes mellitus (DM) during acute coronary syndrome hospitalization is still under debate.MethodsA systematic search of databases (MEDLINE [1985 to March 2012], EMBASE [1985 to March 2012]) was conducted. All prospective cohort studies assessing the accuracy or reproducibility of an OGTT in ACS or non-ACS individuals were included. A bivariate model was used to calculate the pooled sensitivity (SEN), specificity (SPE), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR). Heterogeneity was explored using subgroup analysis and meta-regression.ResultsFifteen studies with 8,027 participants were included (10 ACS and 5 non-ACS studies). The pooled results on SEN, SPE, PLR, NLR, and DOR were 0.70 (95% CI, 0.60-0.78), 0.91 (95% CI, 0.86-0.94), 7.6 (95% CI, 4.9-11.7), 0.33 (95% CI, 0.25-0.45), and 23 (95% CI, 12–41), respectively. The OGTT has a slightly lower SPE in diagnosing DM in ACS than in non-ACS patients (0.86 [95% CI 0.81-0.92] versus 0.95 [95% CI 0.93-0.98], p<0.01), while the SEN values are comparable (0.71 [95% CI 0.60-0.82] versus 0.67 [95% CI 0.54-0.81], p=0.43). After adjusting the interval between repeated tests and age, the meta-regression did not show a difference in DOR between ACS and non-ACS studies.ConclusionsDespite the discrepancy in the interval between the two OGTTs, performing an OGTT in patients with ACS provides accuracy that is similar to that in in non-ACS patients. It is reasonable to screen patients hospitalized for ACS for previously undiagnosed DM using an OGTT.

show abstract

“…Предпочтительный целевой уро-вень глюкозы крови для большинства пациентов состав-ляет 7,7-10 ммоль/л -уровень доказательности А [17].…”

Section: стратегия контроля уровня гликемииunclassified

Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)

2016

View full text Add to dashboard Cite

show abstract

Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome

Cited by 46 publications

References 108 publications

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

The oral glucose tolerance test for the diagnosis of diabetes mellitus in patients during acute coronary syndrome hospitalization: a meta-analysis of diagnostic test accuracy

Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)

Contact Info

Product

Resources

About